General characteristics |
|
|
|
|
Age/years, x±s
|
63.8±8.7 |
63.1±13.2 |
0.408 |
0.684 |
Male, n(%) |
68 (80.0) |
66 (77.6) |
0.141 |
0.707 |
BMI/(kg/m2), x±s
|
25.5±2.7 |
25.1±3.3 |
0.865 |
0.388 |
Coronary artery and cardiac function |
|
|
|
|
Coronary artery lesions≥3, n(%) |
52 (61.2) |
54 (63.3) |
0.100 |
0.752 |
History of PCI, n(%) |
29 (34.1) |
21 (24.7) |
1.813 |
0.178 |
LVDd/mm, x±s
|
48.4±8.4 |
47.9±9.8 |
0.357 |
0.772 |
EF/%, x±s
|
52.2±5.7 |
53.3±8.5 |
-0.991 |
0.323 |
Cardiac-related complications |
|
|
|
|
HBP, n(%) |
50 (58.8) |
52 (61.2) |
0.098 |
0.754 |
History of myocardial infarction, n(%) |
17 (20.0) |
21 (24.7) |
0.542 |
0.461 |
Congestive heart failure, n(%) |
2 (2.3) |
1 (1.2) |
0.339 |
1.000 |
Non-cardiac-related complications |
|
|
|
|
Hypercholesterolemia, n(%) |
12 (14.1) |
11 (14.0) |
0.050 |
0.823 |
Diabetes, n(%) |
25 (29.4) |
33 (38.9) |
1.675 |
0.196 |
Chronic lung disease, n(%) |
0 (0.0) |
5 (5.9) |
5.152 |
0.059 |
History of cerebrovascular disease, n(%) |
5 (5.8) |
3 (3.8) |
0.525 |
0.720 |
Peripheral vascular disease, n(%) |
1 (1.2) |
2 (2.3) |
0.330 |
1.000 |
Creatinine /(μmol/L), x±s
|
66.7±15.2 |
72.5±22.5 |
-1.969 |
0.051 |